Treatment for Type-2-Diabetes News: Fixed Combination of DPP-4 and SGLT-2 Inhibitors

被引：0
|
作者：
不详
机构：
来源：
DIABETES STOFFWECHSEL UND HERZ | 2018年 / 27卷 / 03期
关键词：
TYPE-2; DIABETES-MELLITUS; MILLION PEOPLE; SITAGLIPTIN; THERAPY; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [1] Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
    Singh, Awadhesh Kumar
    Singh, Ritu
    WORLD JOURNAL OF DIABETES, 2022, 13 (06) : 466 - 470
  • [2] Type 2 Diabetes Comorbidities and Treatment Challenges: Rationale for DPP-4 Inhibitors
    Hollander, Priscilla A.
    Kushner, Pamela
    POSTGRADUATE MEDICINE, 2010, 122 (03) : 71 - 80
  • [3] An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitors
    Lamos, Elizabeth Mary
    Hedrington, Maka
    Davis, Stephen N.
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (08) : 691 - 701
  • [4] Novel combination treatment of type 2 diabetes DPP-4 inhibition
    Ahren, Bo
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (02) : 383 - 394
  • [5] Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis
    Mishriky, B. M.
    Tanenberg, R. J.
    Sewell, K. A.
    Cummings, D. M.
    DIABETES & METABOLISM, 2018, 44 (02) : 112 - 120
  • [6] SGLT-2 Inhibitors and DPP-4 Inhibitors as Second-Line Drugs in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials
    Wang, Keke
    Zhang, Yansong
    Zhao, Chunyang
    Jiang, Mingyan
    HORMONE AND METABOLIC RESEARCH, 2018, 50 (10) : 768 - 777
  • [7] DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews
    Ling, Juan
    Ge, Long
    Zhang, Ding-hua
    Wang, Yong-feng
    Xie, Zhuo-lin
    Tian, Jin-hui
    Xiao, Xiao-hui
    Yang, Ke-hu
    ACTA DIABETOLOGICA, 2019, 56 (01) : 7 - 27
  • [8] Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
    Cristiana Vitale
    Giuseppe M. C. Rosano
    Krishna Prasad
    Cardiovascular Diabetology, 15
  • [9] Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
    Vitale, Cristiana
    Rosano, Giuseppe M. C.
    Prasad, Krishna
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [10] Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
    Deacon, Carolyn F.
    PEPTIDES, 2018, 100 : 150 - 157
12345